| P50 | author | Davide Bolignano | Q37371425 |
| | Giuseppe Coppolino | Q37371444 |
| P2093 | author name string | Anna Pisano | |
| | Graziella D'Arrigo | |
| P2860 | cites work | Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates | Q24187349 |
| | Estimating the mean and variance from the median, range, and the size of a sample | Q24801782 |
| | Mechanisms of anemia in CKD. | Q27693202 |
| | Measuring inconsistency in meta-analyses | Q27860655 |
| | K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 |
| | Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes | Q33985838 |
| | Pentoxifylline for sickle-cell disease | Q34028684 |
| | Prevalence of anemia in chronic kidney disease in the United States | Q35083495 |
| | Impact of pentoxifylline and vitamin e on ribavirin-induced haemolytic anaemia in chronic hepatitis C patients: an egyptian survey | Q35207742 |
| | Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial | Q37313722 |
| | Emerging therapies for chronic kidney disease: what is their role? | Q37489497 |
| | Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes | Q57396250 |
| | An Economic Evaluation of Erythropoiesis-Stimulating Agents in CKD | Q63681895 |
| | Role of pentoxifylline in treatment of anemic patients suffering chronic hemodialysis: a randomized clinical trial | Q83836600 |
| | Do pentoxifylline and ascorbic acid improve erythropoiesis stimulating agent resistance? | Q84620329 |
| | Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial | Q85035181 |
| | Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients | Q87113230 |
| | Pentoxifylline does not alter the concentration of hepcidin in chronic kidney disease patients undergoing hemodialysis | Q87418428 |
| | Anaemia management and mortality risk in chronic kidney disease | Q38084470 |
| | Immune cell dysfunction and inflammation in end-stage renal disease | Q38090908 |
| | Pentoxifylline in heart failure: a meta-analysis of clinical trials. | Q38206557 |
| | Pentoxifylline, Ciprofloxacin and Dexamethasone Improve the Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients; Malignancy | Q40702666 |
| | Effects of pentoxifylline on the haematologic status in anaemic patients with advanced renal failure | Q42473068 |
| | Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease | Q43063199 |
| | Immunomodulatory properties of pentoxifylline are mediated via adenosine-dependent pathways | Q43227039 |
| | Pentoxifylline for the treatment of hemolytic anemia in a patient who developed recurrent gastrointestinal bleeding while on continuous-flow left ventricular assist device support | Q44014831 |
| | Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy | Q44486191 |
| | Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure | Q44948985 |
| | Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial | Q46122694 |
| | Effect of pentoxifylline on anaemia control in haemodialysis patients: retrospective observational case-control study. | Q46624708 |
| | The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients | Q47860343 |
| | A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial | Q48068592 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anemia | Q5445 |
| | heterocyclic compound | Q193430 |
| | chronic renal insufficiency | Q736715 |
| | pentoxifylline | Q416331 |
| | systematic review | Q1504425 |
| | mechanism of action | Q3271540 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e0134104 | |
| P577 | publication date | 2015-08-03 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis | |
| P478 | volume | 10 | |